Viewing nowAmerid Tablet (Gliclazide)
Glimepiride 2mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

MFDS item code 200404038 · Notified 2004.10.07 · Insurance code 663601120
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to assist in controlling blood sugar levels in patients with type 2 diabetes, in conjunction with diet and exercise. It may be used alone or in combination with oral hypoglycemic agents or insulin. Particularly in cases where blood sugar control is inadequate, it may enhance effectiveness when combined with sulfonylureas or metformin. This medication helps effectively manage blood sugar, thereby improving blood sugar control for patients.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering drug to this drug There is no exact dose equivalence between this drug and other oral glucose-lowering drugs. When switching from another oral glucose-lowering drug to this drug, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered drug. 4) Dose monitoring and adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily, if possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this drug and metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to identify the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may be increased. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis. Avoid taking this medication if you have an allergy to it or any of its components. It is recommended not to use this medication in patients with severely impaired liver or kidney function. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, those before or after surgery, or those who have suffered major trauma are advised to receive insulin therapy instead of this medication. Caution should be taken if there are gastrointestinal disturbances such as diarrhea or vomiting, as this may prevent proper absorption of the medication and increase the risk of hypoglycemia. During the initial stages of treatment, the risk of hypoglycemia is high; hence, blood glucose levels should be monitored frequently, particularly in elderly patients, those with poor nutritional status, or individuals with irregular eating habits. Patients who frequently consume alcohol or have weakened kidney or liver function may also react more sensitively to this medication. If taking other medications, consult with a physician or pharmacist as interactions may affect blood sugar control. If symptoms of hypoglycemia occur, it is important to consume carbohydrates immediately, and if symptoms are severe, seek medical attention promptly. This medication should be taken in conjunction with regular meals, exercise, and weight management for optimal effectiveness. In cases of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment and care following the physician's directions. Store this medication out of reach of children and keep it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature at room temperature between 1 to 30 degrees Celsius.
Green rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.